1 Short‐term visual acuity from 20/20 to 20/40 |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
2 Long‐term visual acuity between 20/20 and 20/40 |
2 |
108 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.03 [0.82, 1.29] |
3 Final visual acuity between 20/20 and 20/40 |
2 |
143 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.05 [0.93, 1.18] |
4 Time to resolution of primary hemorrhage (days) |
|
|
Other data |
No numeric data |
5 Risk of secondary hemorrhage |
6 |
330 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.28 [0.13, 0.60] |
6 Time to rebleed (days) |
|
|
Other data |
No numeric data |
7 Risk of corneal blood stain |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
8 Risk of glaucoma or increases in IOP |
|
|
Other data |
No numeric data |
8.1 Transient increase in IOP |
|
|
Other data |
No numeric data |
8.2 Persistent increase in IOP |
|
|
Other data |
No numeric data |
9 Risk of glaucoma or elevated IOP |
2 |
83 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.38 [0.08, 1.82] |
10 Risk of optic atrophy |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
11 Adverse effects: nausea or vomiting |
3 |
131 |
Risk Ratio (M‐H, Fixed, 95% CI) |
8.60 [2.09, 35.50] |
12 Duration of hospitalization (days) |
|
|
Other data |
No numeric data |